Biomarkers for activation of the inflammatory and immune systems in the risk of mortality in critically-ill COVID-19 patients
A. Vassiliou (Athens, Greece), A. Zacharis (Athens, Greece), C. Keskinidou (Athens, Greece), E. Jahaj (Athens, Greece), P. Gallos (Athens, Greece), N. Athanasiou (Athens, Greece), S. Tsipilis (Athens, Greece), I. Dimopoulou (Athens, Greece), A. Kotanidou (Athens, Greece), S. Orfanos (Athens, Greece)
Source: Virtual Congress 2021 – Respiratory failure in COVID19 and beyond
Session: Respiratory failure in COVID19 and beyond
Session type: E-poster
Number: 3321
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Vassiliou (Athens, Greece), A. Zacharis (Athens, Greece), C. Keskinidou (Athens, Greece), E. Jahaj (Athens, Greece), P. Gallos (Athens, Greece), N. Athanasiou (Athens, Greece), S. Tsipilis (Athens, Greece), I. Dimopoulou (Athens, Greece), A. Kotanidou (Athens, Greece), S. Orfanos (Athens, Greece). Biomarkers for activation of the inflammatory and immune systems in the risk of mortality in critically-ill COVID-19 patients. 3321
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: